References

Cannabidiol: Pharmacology and Potential Therapeutic Role in Epilepsy and Other Neuropsychiatric Disorders

10.1111/epi.12631 · 2014 · External reference

Cannabidiol: State of the Art and New Challenges for Therapeutic Applications

10.1016/j.pharmthera.2017.02.041 · 2017 · External reference

Cannabidiol Aqueous Solubility Enhancement: Comparison of Three Amorphous Formulations Strategies Using Different Type of Polymers

10.1016/j.ijpharm.2020.119812 · 2020 · External reference

Current Challenges and Opportunities for Improved Cannabidiol Solubility

10.3390/ijms241914514 · 2023 · External reference

Nanoformulations as a Strategy to Overcome the Delivery Limitations of Cannabinoids

10.1002/ptr.7742 · 2023 · External reference

A Comprehensive Update on Cannabidiol, Its Formulations and Drug Delivery Systems

10.1007/s11101-024-10001-9 · 2025 · External reference

Synthesis of (−)‐Cannabidiol (CBD), (−)‐Δ9‐ and (−)‐Δ8‐Tetrahydrocannabinols, Encapsulation of CBD With Nanoparticles for Controlled Delivery and Biological Evaluation

10.1002/chem.202402496 · 2024 · External reference

Enhanced Metabolic Syndrome Management Through Cannabidiol‐Loaded PLGA Nanoparticles: Development and In Vitro Evaluation

10.1002/jbm.a.37916 · 2025 · External reference

CBD‐Loaded Nanostructured Lipid Carriers: Optimization, Characterization, and Stability

10.1021/acsomega.4c04771 · 2024 · External reference

Enhancing Cannabinoid Bioavailability: A Crossover Study Comparing a Novel Self‐Nanoemulsifying Drug Delivery System and a Commercial Oil‐Based Formulation

10.1186/s42238-025-00294-8 · 2025 · External reference

Formulation and Evaluation of Solid Self‐Nanoemulsifying Drug Delivery System of Cannabidiol for Enhanced Solubility and Bioavailability

10.3390/pharmaceutics17030340 · 2025 · External reference

Label Accuracy of Unregulated Cannabidiol (CBD) Products: Measured Concentration vs. Label Claim

10.1186/s42238-022-00140-1 · 2022 · External reference

Cannabinoid Content and Label Accuracy of Hemp‐Derived Topical Products Available Online and at National Retail Stores

10.1001/jamanetworkopen.2022.23019 · 2022 · External reference

CBD Products: Labeling Accuracy of an Obscure Niche Market

10.1016/j.foodcont.2024.110375 · 2024 · External reference

A Review on the Recent Advances in HPLC, UHPLC and UPLC Analyses of Naturally Occurring Cannabinoids (2010–2019)

10.1002/pca.2906 · 2020 · External reference

Commercial Cannabis Consumer Products Part 2: HPLC‐DAD Quantitative Analysis of Cannabis Cannabinoids

10.1016/j.forsciint.2018.05.033 · 2018 · External reference

Combination of UV and MS/MS Detection for the LC Analysis of Cannabidiol‐Rich Products

10.1016/j.talanta.2020.121250 · 2020 · External reference

Recent HPLC‐UV Approaches for Cannabinoid Analysis: From Extraction to Method Validation and Quantification Compliance

10.3390/ph18060786 · 2025 · External reference

Quantitation of Cannabinoids in Cannabis Dried Plant Materials, Concentrates, and Oils Using Liquid Chromatography–Diode Array Detection Technique With Optional Mass Spectrometric Detection: Single‐Laboratory Validation Study, First Action 2018.11

10.5740/jaoacint.18-0426 · 2019 · External reference

Recent Advanced Methods for Extracting and Analyzing Cannabinoids from Cannabis‐Infused Edibles and Detecting Hemp‐Derived Contaminants in Food (2013–2023): A Comprehensive Review

10.1021/acs.jafc.4c01286 · 2024 · External reference

Extraction and Analysis of Cannabinoids: A Decade of Progress, Challenges and Future Directions

10.1016/j.chroma.2025.466321 · 2025 · External reference

Evaluation of Different Extraction Procedures for the Quantification of Seven Cannabinoids in Cannabis‐Based Edibles by the Use of LC‐MS

10.1016/j.jfca.2022.104915 · 2023 · External reference

Challenges of Cannabidiol Determination in Emulsified Cosmetics and Application of Solid‐Phase Extraction Followed by HPLC‐UV‐MS/MS

10.1007/s00216-024-05716-9 · 2025 · External reference

Multi‐Analyst, Multi‐Matrix Performance of the QuEChERS Approach for Pesticide Residues in Foods and Feeds Using HPLC/MS/MS Analysis With Different Calibration Techniques

10.1093/jaoac/93.2.355 · 2010 · External reference

Overview of the Evolution and Trends of the QuEChERS Sample Preparation Procedure

10.1007/s44169-024-00073-1 · 2024 · External reference

Development, Validation and Application of a LC‐MS/MS Method for Quantification of 15 Cannabinoids in Food

10.1016/j.foodchem.2020.126469 · 2020 · External reference

Development and Validation of LC‐MS/MS Method With QuEChERS Clean‐Up for Detecting Cannabinoids in Foods and Dietary Supplements

10.1080/19440049.2020.1769200 · 2020 · External reference

Development of an LC‐MS‐Based Method to Study the Fate of Nanoencapsulated Pesticides in Soils and Strawberry Plant

10.1016/j.talanta.2021.123093 · 2022 · External reference

Formulation and Chemical Stability in Aqueous Media of Cannabidiol Embedded in Cardanol‐Based Nanovesicles

10.1021/acssuschemeng.7b01658 · 2017 · External reference

PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and in Ovo Assessment

10.3390/pharmaceutics12050439 · 2020 · External reference

Mucoadhesive Nanostructured Lipid Carriers as a Cannabidiol Nasal Delivery System for the Treatment of Neuropathic Pain

10.1016/j.ejps.2020.105698 · 2021 · External reference

Preparation, Stability, Antioxidative Property and In Vitro Release of Cannabidiol (CBD) in Zein‐Whey Protein Composite Nanoparticles

10.1016/j.lwt.2022.113466 · 2022 · External reference

Development and Characterization of Nanostructured Lipid Carriers for Cannabidiol Delivery

10.1016/j.foodchem.2023.138295 · 2024 · External reference

Novel Intravenous Nanoemulsions Based on Cannabidiol‐Enriched Hemp Oil—Development and Validation of an HPLC‐DAD Method for Cannabidiol Determination

10.3390/molecules30020278 · 2025 · External reference

Development and Pharmacokinetic Evaluation of a Self‐Nanoemulsifying Drug Delivery System for the Oral Delivery of Cannabidiol

10.1016/j.ejps.2021.106058 · 2022 · External reference

Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single‐Dose Administration of Different Formulations

10.3390/molecules30132676 · 2025 · External reference

Enhancement of Cannabidiol Oral Bioavailability Through the Development of Nanostructured Lipid Carriers: In Vitro and In Vivo Evaluation Studies

10.1007/s13346-024-01766-9 · 2025 · External reference

Development of a Novel Nano‐Emulsion Formulation to Improve Intestinal Absorption of Cannabidiol

10.1159/000497361 · 2019 · External reference

Absorption and Bioavailability of Novel UltraShear Nanoemulsion of Cannabidiol in Rats

10.1159/000534473 · 2023 · External reference

Quantitation of Cannabidiol (CBD) in Brain Regions and Plasma Following Intranasal Administration of a CBD Nanoformulation

10.1186/s42238-025-00308-5 · 2025 · External reference

Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson's Rats

10.3390/pharmaceutics16040514 · 2024 · External reference

Unresolved reference

2022 · External reference

System Suitability Requirements for Liquid Chromatography Methods: Controlled Parameters and their Recommended Values (Review)

10.1007/s11094-020-02231-w · 2020 · External reference

Enhanced Stability and Oral Bioavailability of Cannabidiol in Zein and Whey Protein Composite Nanoparticles by a Modified Anti‐Solvent Approach

10.3390/foods11030376 · 2022 · External reference

Strategies for Controlling Particle Size in Injectable Nanosuspensions and Emulsions: Techniques and Future Opportunities

10.1155/adpp/3632073 · 2025 · External reference

Particle Engineering in Dry Powders for Inhalation

10.1016/j.ejps.2022.106158 · 2022 · External reference

Fast and Reliable Profiling of Cannabinoids in Seized Samples Using the Method of HPLC–DAD Followed by Chemometrics

10.1007/s11419-022-00625-x · 2022 · External reference

Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS

10.1021/ac020361s · 2003 · External reference

Qualitative and Quantitative Measurement of Cannabinoids in Cannabis Using Modified HPLC/DAD Method

10.1016/j.jpba.2017.07.021 · 2017 · External reference

Stability Characteristics of Cannabidiol for the Design of Pharmacological, Biochemical and Pharmaceutical Studies

10.1016/j.jchromb.2020.122188 · 2020 · External reference

Cannabidiol‐Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti‐Inflammatory Activity

10.3390/pharmaceutics15020537 · 2023 · External reference

Solid Lipid Nanoparticles: Production, Characterization and Applications

10.1016/j.addr.2012.09.021 · 2012 · External reference

CBD, A Precursor of THC in E‐Cigarettes

10.1038/s41598-021-88389-z · 2021 · External reference

The Essential Medicinal Chemistry of Cannabidiol (CBD)

10.1021/acs.jmedchem.0c00724 · 2020 · External reference

Cellular Uptake of Nanoparticles: Journey Inside the Cell

10.1039/c6cs00636a · 2017 · External reference

Toxicity and Cellular Uptake of Lipid Nanoparticles of Different Structure and Composition

10.1016/j.jcis.2020.05.002 · 2020 · External reference

The Internal Nanostructure of Lipid Nanoparticles Influences Their Diverse Cellular Uptake Pathways

10.1002/smll.202500903 · 2025 · External reference

Cannabidiol Loaded Nanoemulsion With Improved Bioaccessibility and Anti‐Inflammatory Activity

10.1021/acsomega.5c04608 · 2025 · External reference

Application of the QuEChERS Procedure for Analysis of Δ9‐Tetrahydrocannabinol and Its Metabolites in Authentic Whole Blood Samples by GC–MS/MS

10.1007/s11419-018-0419-8 · 2018 · External reference